Company / Operating Cash Flow per Share
IMMUCELL CORP /DE/ Operating Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.04
FY2025
5-year range
-$0.60 / $0.95
FY2021-FY2025
Trend
+106.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $0.04.
Based on SEC 10-K filings.
0.04 in FY2025 with a 10-year CAGR of -19.7%.
Improved from $-0.20 to $0.04 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -19.7%
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 106.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +106.6% |
| FY2024 | -$0.60 | -202.6% |
| FY2023 | -$0.20 | -334.5% |
| FY2017 | -$0.05 | -104.8% |
| FY2016 | $0.95 | +166.6% |
| FY2015 | $0.36 | +221.4% |
| FY2014 | $0.11 | +986.2% |
| FY2013 | -$0.01 | +95.4% |
| FY2012 | -$0.27 | -634.4% |
| FY2011 | -$0.04 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026